Insurance Coverage Policies for Personalized Medicine

Adoption of personalized medicine in practice has been slow, in part due to the lack of evidence of clinical benefit provided by these technologies. Coverage by insurers is a critical step in achieving widespread adoption of personalized medicine. Insurers consider a variety of factors when formulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hresko, Andrew, Haga, Susanne B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251376/
https://www.ncbi.nlm.nih.gov/pubmed/25562360
http://dx.doi.org/10.3390/jpm2040201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251376/
https://www.ncbi.nlm.nih.gov/pubmed/25562360
http://dx.doi.org/10.3390/jpm2040201

Ejemplares similares